International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.
about
Reliability analysis of the Chinese version of the Functional Assessment of Cancer Therapy - Leukemia (FACT-Leu) scale based on multivariate generalizability theory.How could patient reported outcomes improve patient management in chronic myeloid leukemia?Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?Chronic Myeloid Leukemia in India.Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment.Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia.Treatment recommendations for chronic myeloid leukemiaVariables associated with patient-reported outcomes in persons with chronic myeloid leukemia receiving tyrosine kinase-inhibitor therapy.Psychological well-being and social support in chronic myeloid leukemia patients receiving lifelong targeted therapies.A critical history of chromic myeloid leukemiaMoving towards patient-centered decision-making in chronic myeloid leukemia: assessment of quality of life and symptom burdenPhysicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients.Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment.Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia.The impact of new generic formulations of imatinib mesylate on general quality of life in chronic phase chronic myeloid leukaemia patients.Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials.Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.Chronic myeloid leukemia patients and treatment-free remission attitudes: a multicenter survey.Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire.
P2860
Q29994768-F476CA92-F1A5-402C-BB3A-6300B5F74E17Q30241092-DA2FD730-6022-4DA7-AD59-4506C2BDE6B9Q30242015-C863FBDE-491C-415F-9B97-AF54B8A30C23Q33859551-9F5D8128-8264-4E99-A0BC-19C659415D87Q36368297-1FBE7882-2CAE-466D-B554-84E80417B958Q37676310-AED43653-2D40-418E-924C-B40D1ACC16B9Q38181112-E8F93335-B329-492C-871A-67339F3274C9Q38934423-8D86B5EE-F0F1-492B-8832-B1FE52000387Q39569852-ACDA3429-C6CF-42ED-BEC6-BEF2FEEF9BFEQ41877378-1549D1A9-333D-4A91-AC72-B0CBEE22A764Q42633004-37CD6362-BD3A-4F3B-A1F0-1EAB4D3AB6E1Q42672393-73DFE41B-E9FE-4ED0-AB01-25FA4F419282Q47135575-8941B2F8-70F1-429B-B504-78A4EE5518A6Q47551814-90B76BBE-74DB-4A3A-9D3F-0A94AF6B2189Q47617369-FEAA108E-EB86-4A9F-989C-AB77F847EC6AQ48319994-4B54736D-C995-4B08-967A-6026BFEF723DQ52612544-8E7BE29D-BB20-4CDD-872B-95A497B8BB46Q55345383-114ABAC7-D117-4F9D-82CA-E6E0985FA0ACQ55491433-29BFFCBA-112C-4AA4-8FE5-69E4729320D6
P2860
International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
International development of a ...... patients: the EORTC QLQ-CML24.
@en
International development of a ...... patients: the EORTC QLQ-CML24.
@en-gb
International development of a ...... patients: the EORTC QLQ-CML24.
@nl
type
label
International development of a ...... patients: the EORTC QLQ-CML24.
@en
International development of a ...... patients: the EORTC QLQ-CML24.
@en-gb
International development of a ...... patients: the EORTC QLQ-CML24.
@nl
prefLabel
International development of a ...... patients: the EORTC QLQ-CML24.
@en
International development of a ...... patients: the EORTC QLQ-CML24.
@en-gb
International development of a ...... patients: the EORTC QLQ-CML24.
@nl
P2093
P2860
P50
P921
P1476
International development of a ...... patients: the EORTC QLQ-CML24.
@en
P2093
Adel Naeem
Annarita Cardoni
Felice Bombaci
Franco Mandelli
Francois Guilhot
Giora Sharf
Gregory Abel
Lucien Noens
Marzia Salvucci
Ourania Nicolatou-Galitis
P2860
P2888
P304
P356
10.1007/S11136-013-0523-5
P50
P577
2013-09-13T00:00:00Z